1The Daugirdas Second-Generation Formula
Single-pool Kt/V (spKt/V) models the patient as a single well-mixed compartment for urea distribution. The second-generation formula developed by John T. Daugirdas corrects for both ongoing urea generation during the session and the significant convective contribution of fluid removal (ultrafiltration):
spKt/V = −ln(R − 0.008 × t) + (4 − 3.5 × R) × (UF ÷ V)
URR (%) = (1 − R) × 100
Where: R = post-dialysis BUN ÷ pre-dialysis BUN; t = session duration in decimal hours; UF = ultrafiltration volume in litres; V = post-dialysis weight in kilograms.
2KDOQI 2015 Hemodialysis Adequacy Benchmarks
| Delivered spKt/V | Equivalent URR | Clinical Interpretation | Action Directive |
|---|---|---|---|
| ≥ 1.40 | ≥ 70% | Adequate | Target achieved. Maintain prescription; recheck adequacy monthly. |
| 1.20 – 1.39 | 65% – 69% | Borderline | Below minimum safety buffer. Extend time or increase blood flow (Qb); recheck next session. |
| < 1.20 | < 65% | Inadequate | Urgent prescription overhaul; rule out vascular access recirculation or early clot formation. |
3Prescription Optimization for Low Kt/V
- Extend Session Duration (t): The most physiologically effective adjustment. Adding 30 minutes increases delivered Kt/V by approximately 10% to 15% and dramatically reduces intradialytic cardiovascular strain.
- Increase Blood Pump Flow (Qb): Increase from 300 mL/min to 350–400 mL/min when the AV fistula or catheter allows negative arterial pressures > −200 mmHg.
- Increase Dialysate Flow (Qd): Step up from standard 500 mL/min to 700–800 mL/min to maintain a steep trans-membrane concentration gradient.
- Upgrade to High-Flux Dialyser: Select dialysers with larger surface areas (1.8–2.1 m²) and high ultrafiltration coefficients (Kuf > 40 mL/h/mmHg).
- Rule Out Access Recirculation: Access recirculation > 10% causes dialysed blood to loop directly back into the arterial line, artificially capping clearance.
4Mandatory Slow-Flow Post-BUN Sampling Protocol
Faulty sampling technique is the single leading cause of spurious Kt/V values:
The 30-Second Slow-Flow Protocol:
1. Turn ultrafiltration (UF) off.
2. Drop blood pump speed (Qb) down to 50–100 mL/min for 15 seconds to clear the access line of recirculated blood.
3. Collect the post-dialysis sample from the arterial sampling port within 30 seconds of slowing the pump.
Failure to follow this protocol draws freshly cleared access blood, producing an artificially low post-BUN and a falsely inflated Kt/V.
1. Turn ultrafiltration (UF) off.
2. Drop blood pump speed (Qb) down to 50–100 mL/min for 15 seconds to clear the access line of recirculated blood.
3. Collect the post-dialysis sample from the arterial sampling port within 30 seconds of slowing the pump.
Failure to follow this protocol draws freshly cleared access blood, producing an artificially low post-BUN and a falsely inflated Kt/V.
5Frequently Asked Questions
What is the difference between single-pool Kt/V (spKt/V) and equilibrated Kt/V (eKt/V)?+
Single-pool Kt/V assumes urea equilibrates instantly throughout total body water. In reality, urea in intracellular pools lags behind intravascular clearance. Over 30 to 60 minutes post-dialysis, intracellular urea shifts into plasma (post-dialysis urea rebound). Equilibrated Kt/V (eKt/V) accounts for this rebound: eKt/V ≈ spKt/V − (0.6 ÷ t) (where t is session hours). The KDOQI minimum eKt/V benchmark is ≥ 1.20.
Can URR replace Kt/V in clinical quality monitoring?+
While URR is convenient for rapid chairside assessments, it fails to account for convective clearance from ultrafiltration and fluid shifts. Consequently, URR systematically underestimates total dose in patients requiring substantial volume removal. Formal adequacy audits must rely on spKt/V.
Why is the KDOQI target set at ≥1.4 when the minimum is ≥1.2?+
Prescribing an exact target of 1.2 leaves zero clinical margin for day-to-day variations such as shortened run times, blood pump interruptions, or cannula repositioning. Targeting 1.4 guarantees that delivered clearance remains well above the 1.2 survival threshold across consecutive cycles.
Clinical Disclaimer: Kt/V is a primary index of small-solute clearance. Complete dialysis adequacy requires holistic clinical synthesis: achievement of true dry weight, interdialytic blood pressure control, mineral-bone disease management (calcium/phosphate), and assessment of middle-molecule clearance.